Most Active Stocks

COCHINSHIP
JUBLINGREA
BSE
SCI
INDIGO
GRSE
BEL
RELIANCE
HAL
HDFCBANK
INFY
ICICIBANK
RPOWER
CDSL
MAZDOCK
ONGC
BAJFINANCE
KOTAKBANK
OIL
SBIN

GlaxoSmithKline Pharmaceuticals Limited

Drug Manufacturers - General | Healthcare

Company Overview

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. It provides vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella, and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also offers specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Key Information

Market Cap

581350588416

Current Price

3431.7

52 Week Range

1921.0 - 3515.7

Previous Close

3398.4

Open

3402.1

Industry

Drug Manufacturers - General

Sector

Healthcare

Contact Details

Address

GSK House, Dr. Annie Besant Road Worli, Mumbai, 400030, India

Phone

+91-22249-59595

Fax

+91-22249-59494

Website

https://india-pharma.gsk.com

Financials

Day Low

3401.0

Day High

3467.0

Dividend Yield

1.24

PE Ratio

62.72528

Earnings Per Share

54.71

Beta

0.038

EBITDA

11527068672

Book Value

115.185

EPS

61.375

Company Officers

Name Title Age Year Born
Mr. Bhushan Akshikar MD & Executive Director - -
Mr. Juby Chandy Whole-Time Director & CFO 46 1978
Ms. Aparajita Rajput Vice President of Technology - -
Mr. Ajay Avinash Nadkarni VP of Administration & Real Estate and Company Secretary - -
Mr. Amit G. Pandey Executive Vice President of Legal - -
Ms. Simrat Sohal Vice President of Ethics & Compliance - -
Mr. Carson Dalton Executive Vice President of Communications & Government Affairs - -
Mr. Chinmay Sharma Executive Vice President of Human Resources - -
Ms. Sukanya Choudhary Head of Growth Emerging Market - -
Ms. Sharmishta Mitra Commercial Head - Paediatric Vaccines - -

Company Details

Stock History

Explore More Stocks